Financhill
Sell
43

QURE Quote, Financials, Valuation and Earnings

Last price:
$22.74
Seasonality move :
13.74%
Day range:
$24.77 - $25.79
52-week range:
$6.11 - $71.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
87.06x
P/B ratio:
6.94x
Volume:
2.2M
Avg. volume:
3.7M
1-year change:
297.5%
Market cap:
$1.6B
Revenue:
$27.1M
EPS (TTM):
-$4.39

Analysts' Opinion

  • Consensus Rating
    uniQure NV has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $58.48, uniQure NV has an estimated upside of 129.5% from its current price of $25.48.
  • Price Target Downside
    According to analysts, the lowest downside price target is $37.09 representing 100% downside risk from its current price of $25.48.

Fair Value

  • According to the consensus of 11 analysts, uniQure NV has 129.5% upside to fair value with a price target of $58.48 per share.

QURE vs. S&P 500

  • Over the past 5 trading days, uniQure NV has underperformed the S&P 500 by -8.88% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • uniQure NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • uniQure NV has grown year-over-year revenues for 1 quarter straight. In the most recent quarter uniQure NV reported revenues of $3.7M.

Earnings Growth

  • uniQure NV earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter uniQure NV reported earnings per share of -$1.38.
Enterprise value:
1.4B
EV / Invested capital:
1.87x
Price / LTM sales:
87.06x
EV / EBIT:
--
EV / Revenue:
90.45x
PEG ratio (5yr expected):
-0.66x
EV / Free cash flow:
-9.25x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.3M
Return On Assets:
-35.83%
Net Income Margin (TTM):
-1492.9%
Return On Equity:
-382.35%
Return On Invested Capital:
-40.98%
Operating Margin:
-1370.5%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $111.9M $28.6M $15.8M $2.3M $3.7M
Gross Profit $95.4M -$10.4M -$2.3M -$1.7M -$329K
Operating Income -$132.9M -$203.1M -$193.1M -$37.7M -$50.7M
EBITDA -$122.9M -$190.6M -$176.9M -$34.7M -$47.1M
Diluted EPS -$4.80 -$4.96 -$4.39 -$0.91 -$1.38
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $593.8M $464.6M $693.6M $464.1M $716.2M
Total Assets $774.6M $638.2M $871.6M $645.8M $888.4M
Current Liabilities $41.9M $64M $68.6M $71.3M $100.6M
Total Liabilities $183.9M $217.1M $602.8M $590M $659.6M
Total Equity $590.8M $421.2M $268.8M $55.8M $228.7M
Total Debt $107M $132.3M $514.1M $490M $527.7M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$152.7M -$179.4M -$154M -$38.3M -$17.8M
Cash From Investing -$430.7M $254M $94.4M $50.2M $28.5M
Cash From Financing $365.7M -$57.8M $426.8M -$53.6M $348.1M
Free Cash Flow -$163.1M -$193.1M -$154.1M -$47.1M -$17.7M
QURE
Sector
Market Cap
$1.6B
$28.4M
Price % of 52-Week High
35.64%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-11.27%
-1.32%
1-Year Price Total Return
297.5%
-22.19%
Beta (5-Year)
0.586
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $27.01
200-day SMA
Buy
Level $22.03
Bollinger Bands (100)
Sell
Level 11.34 - 50.08
Chaikin Money Flow
Buy
Level 113.2M
20-day SMA
Sell
Level $28.03
Relative Strength Index (RSI14)
Sell
Level 31.00
ADX Line
Sell
Level 38.87
Williams %R
Buy
Level -89.2587
50-day SMA
Sell
Level $46.22
MACD (12, 26)
Sell
Level -5.10
25-day Aroon Oscillator
Sell
Level -12
On Balance Volume
Neutral
Level 205.7M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-2.2097)
Sell
CA Score (Annual)
Level (-3.2785)
Buy
Beneish M-Score (Annual)
Level (-2.4578)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (4.7943)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

Stock Forecast FAQ

In the current month, QURE has received 9 Buy ratings 2 Hold ratings, and 0 Sell ratings. The QURE average analyst price target in the past 3 months is $58.48.

  • Where Will uniQure NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that uniQure NV share price will rise to $58.48 per share over the next 12 months.

  • What Do Analysts Say About uniQure NV?

    Analysts are divided on their view about uniQure NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that uniQure NV is a Sell and believe this share price will drop from its current level to $37.09.

  • What Is uniQure NV's Price Target?

    The price target for uniQure NV over the next 1-year time period is forecast to be $58.48 according to 11 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is QURE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for uniQure NV is a Buy. 9 of 11 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of QURE?

    You can purchase shares of uniQure NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase uniQure NV shares.

  • What Is The uniQure NV Share Price Today?

    uniQure NV was last trading at $22.74 per share. This represents the most recent stock quote for uniQure NV. Yesterday, uniQure NV closed at $25.48 per share.

  • How To Buy uniQure NV Stock Online?

    In order to purchase uniQure NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock